Trivadi S. Ganesan

5.1k total citations
166 papers, 3.8k citations indexed

About

Trivadi S. Ganesan is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Trivadi S. Ganesan has authored 166 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 59 papers in Molecular Biology and 26 papers in Hematology. Recurrent topics in Trivadi S. Ganesan's work include Ovarian cancer diagnosis and treatment (17 papers), Neutropenia and Cancer Infections (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Trivadi S. Ganesan is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Neutropenia and Cancer Infections (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Trivadi S. Ganesan collaborates with scholars based in India, United Kingdom and United States. Trivadi S. Ganesan's co-authors include Srinivasan Madhusudan, Adrian L. Harris, Jeremy Braybrooke, Frances R. Balkwill, Sudha Sundar, Denis Talbot, David Propper, Venkatraman Radhakrishnan, Andrew N. Shelling and Tenali Gnana Sagar and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Trivadi S. Ganesan

161 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trivadi S. Ganesan India 32 1.7k 1.2k 590 529 484 166 3.8k
Sun‐Young Kong South Korea 32 1.4k 0.8× 1.3k 1.1× 683 1.2× 373 0.7× 425 0.9× 204 3.7k
Ann Zeuner Italy 35 2.4k 1.4× 1.4k 1.1× 867 1.5× 879 1.7× 553 1.1× 72 4.3k
Priscilla N. Kelly Australia 19 2.5k 1.5× 1.3k 1.0× 534 0.9× 746 1.4× 618 1.3× 92 4.4k
Adam S. Asch United States 31 1.7k 1.0× 1.3k 1.0× 579 1.0× 1.0k 1.9× 991 2.0× 98 4.6k
Walter E. Aulitzky Germany 34 1.4k 0.8× 1.1k 0.9× 385 0.7× 502 0.9× 1.1k 2.3× 121 3.6k
Sharon R. Pine United States 27 1.3k 0.8× 1.2k 1.0× 600 1.0× 371 0.7× 217 0.4× 64 2.7k
James F. Beck Germany 36 1.5k 0.9× 1.2k 1.0× 287 0.5× 415 0.8× 950 2.0× 150 3.9k
Edgar Selzer Austria 35 1.7k 1.0× 951 0.8× 525 0.9× 604 1.1× 624 1.3× 106 3.7k
Hans Minderman United States 34 1.7k 1.0× 1.4k 1.2× 450 0.8× 622 1.2× 396 0.8× 90 3.2k

Countries citing papers authored by Trivadi S. Ganesan

Since Specialization
Citations

This map shows the geographic impact of Trivadi S. Ganesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trivadi S. Ganesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trivadi S. Ganesan more than expected).

Fields of papers citing papers by Trivadi S. Ganesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trivadi S. Ganesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trivadi S. Ganesan. The network helps show where Trivadi S. Ganesan may publish in the future.

Co-authorship network of co-authors of Trivadi S. Ganesan

This figure shows the co-authorship network connecting the top 25 collaborators of Trivadi S. Ganesan. A scholar is included among the top collaborators of Trivadi S. Ganesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trivadi S. Ganesan. Trivadi S. Ganesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swaminathan, Rajaraman, et al.. (2023). Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer. Cancer Medicine. 12(10). 11731–11745. 11 indexed citations
2.
Radhakrishnan, Venkatraman, et al.. (2022). Outcomes with chemotherapy in carcinoma penis: Experience from a tertiary cancer center. Indian Journal of Cancer. 60(3). 396–402. 2 indexed citations
3.
Mehra, Nikita, et al.. (2022). Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis. SHILAP Revista de lepidopterología. 11(1). 68–72. 1 indexed citations
4.
Kirtonia, Anuradha, Amit Kumar Pandey, Balaji Ramachandran, et al.. (2022). Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade. Cellular and Molecular Life Sciences. 79(7). 362–362. 45 indexed citations
5.
Nagare, Rohit P., et al.. (2019). Analysis of Human Stem Cell Transcription Factors. Cellular Reprogramming. 21(4). 171–180. 14 indexed citations
6.
Mehra, Nikita, Prasanth Ganesan, Venkatraman Radhakrishnan, et al.. (2018). Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India. Blood. 132(Supplement 1). 4008–4008. 4 indexed citations
7.
Ganesan, Prasanth, Trivadi S. Ganesan, Venkatraman Radhakrishnan, et al.. (2018). Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era. Indian Journal of Hematology and Blood Transfusion. 35(1). 37–42. 7 indexed citations
8.
Ganesan, Prasanth, Venkatraman Radhakrishnan, Trivadi S. Ganesan, et al.. (2018). Prospective evaluation of the toxicity profile, and predictors of toxicity of high dose methotrexate in patients of acute lymphoblastic leukemia/lymphoma. Pediatric Hematology Oncology Journal. 3(1). 1–5. 3 indexed citations
9.
Nagare, Rohit P., et al.. (2018). A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics. Biochemistry and Cell Biology. 96(3). 295–305. 14 indexed citations
10.
11.
Totadri, Sidharth, et al.. (2017). Dietary perceptions and beliefs among families with children undergoing therapy for cancer. SHILAP Revista de lepidopterología. 2(2). 25–28. 6 indexed citations
12.
Ganesan, Trivadi S., et al.. (2017). Perception of stress among yoga trained individuals. National Journal of Physiology Pharmacy and Pharmacology. 1–1. 5 indexed citations
13.
Mishra, Sourav, Venkatraman Radhakrishnan, Prasanth Ganesan, et al.. (2017). Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre. Indian Journal of Hematology and Blood Transfusion. 33(4). 470–476. 3 indexed citations
14.
Emilion, G, Andrew J. Mungall, Ian Dunham, et al.. (2002). The human homologue of unc-93 maps to chromosome 6q27 – characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genetics. 3(1). 20–20. 14 indexed citations
15.
Förster, Jeremy Braybrooke, Srinivasan Madhusudan, et al.. (2002). A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancer. British Journal of Cancer. 86. 1 indexed citations
16.
Propper, David, Jeremy Braybrooke, D.J. Taylor, et al.. (1999). Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours. Annals of Oncology. 10(8). 923–927. 103 indexed citations
17.
Propper, David, Mark Saunders, A. J. Salisbury, et al.. (1999). Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.. PubMed. 5(7). 1682–9. 47 indexed citations
18.
Katso, Roy, Robert B. Russell, & Trivadi S. Ganesan. (1999). Functional Analysis of H-Ryk, an Atypical Member of the Receptor Tyrosine Kinase Family. Molecular and Cellular Biology. 19(9). 6427–6440. 64 indexed citations
19.
Odunsi, Kunle & Trivadi S. Ganesan. (1997). The roles of the human major histocompatibility complex and human papillomavirus infection in cervical intraepithelial neoplasia and cervical cancer. Clinical Oncology. 9(1). 4–13. 14 indexed citations
20.
Philip, P. A., C. Thompson, J. Carmichael, et al.. (1993). A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.. PubMed. 53(23). 5649–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun‐Young Kong Breakdown of academic impact, for papers by Ann Zeuner Breakdown of academic impact, for papers by Priscilla N. Kelly Breakdown of academic impact, for papers by Adam S. Asch Breakdown of academic impact, for papers by Walter E. Aulitzky Breakdown of academic impact, for papers by Sharon R. Pine Breakdown of academic impact, for papers by James F. Beck Breakdown of academic impact, for papers by Edgar Selzer Breakdown of academic impact, for papers by Hans Minderman
Rankless by CCL
2026